Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 237, pseudogene (RN7SL237P) is a human noncoding RNA pseudogene annotated as a member of the processed 7SL RNA pseudogene family. 7SL RNA is normally the RNA component of the signal recognition particle, which regulates cellular protein targeting during translation by tethering ribosomes and nascent peptides to membrane pores for proper protein translocation[5][7]. In contrast, the majority of dispersed 7SL-like sequences in the human genome—including RN7SL237P—are pseudogenes resulting from the reverse flow of genetic information (retrotransposition of 7SL RNA) and are structurally truncated with no coding function[3]. These pseudogenes are not expressed as functional RNAs and do not participate in SRP function or cell signaling, and are generally considered genomic fossils without known clinical or biological impact[1][3]. RN7SL237P is not a drug target, does not act as a receptor, enzyme, or biomarker, and has no known disease associations or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 237, pseudogene (RN7SL237P).